Yahoo Movies Is Five9 Stock a Buy Now?
50% pullback in shares of cloud-based contact center software provider Five9 presents an opportunity for long term investors.
Latest Stories
GuruFocus.comKoninklijke Vopak NV's Dividend Analysis
Koninklijke Vopak NV (VOPKY) recently announced a dividend of $1.63 per share, payable on 2024-05-17, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Koninklijke Vopak NV's dividend performance and assess its sustainability.
- GuruFocus.com
Hochtief AG's Dividend Analysis
Hochtief AG (HOCFF) recently announced a dividend of $4.4 per share, payable on 2024-07-05, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Hochtief AG's dividend performance and assess its sustainability.
- Cover Media
Southwest Drops Service to 4 Airports Amid Boeing Problems
On April 24, Boeing announced that it will keep production levels lower so that it can focus on the quality and safety of its planes. The announcement comes after the company has experienced backlash over safety issues, such as the incident on Jan. 5 in which a door plug flew off of an Alaska Airlines plane.
- Reuters
UPDATE 1-Exxon misses on Q1 profit despite big gains in Guyana
Exxon Mobil Corp on Friday missed analysts' estimates with a 28% year-on-year drop in first quarter profits as weaker refining margins and lower natural gas prices offset volume gains. The largest U.S. oil company, which is in the process of closing a $60 billion deal for top shale oil producer Pioneer Natural Resources, posted first-quarter earnings of $8.22 billion, or $2.06 per share, compared to an $11.43 billion net profit a year ago. The stock was down 2% in pre-market trading to $118.50 after reporting a profit per share of $2.06, 6% shy of Wall Street analysts' consensus for $2.20 per share, LSEG estimates showed.
- Associated Press
Students resume pro-Palestinian protests at a prestigious Paris university after police intervention
Students at a prestigious university in Paris resumed pro-Palestinian protests on Friday, inspired by Gaza solidarity encampments at campuses around the United States, two days after French police broke up another demonstration. About 40 people remained in a building overnight in defiance of administrators who students say called the police on their peers two days earlier.
- PA Media: UK News
Fiona Beal’s original trial halted by defence witness ‘mistake’
The first trial was abandoned in its 17th week after the judge was not informed that a friend of Beal was a staff member at Northampton Crown Court.
- GuruFocus.com
AXA SA's Dividend Analysis
AXA SA(AXAHY) recently announced a dividend of $2.1 per share, payable on 2024-05-21, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into AXA SA's dividend performance and assess its sustainability.
- BBC
Energy firm's battery storage site plans approved
Exagen has been granted permission to go ahead with plans for 16 lithium-ion battery units on land in Brockworth.
- GuruFocus.com
Oceaneering International Inc (OII) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
Explore key financial outcomes and strategic directions from Oceaneering International's first quarter earnings call.
- GuruFocus.com
Rush Enterprises Inc (RUSHA) Q1 2024 Earnings Call Transcript Highlights: Strong Performance ...
Despite a tough economic landscape, Rush Enterprises reports robust Q1 2024 results with strategic insights for future growth.
- GuruFocus.com
The Shyft Group Inc (SHYF) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
Despite a downturn in Q1 earnings, The Shyft Group Inc remains focused on future growth and operational efficiency.
- Investor's Business Daily
Emotional Trauma Might Be Slowing You Down At Work
Unresolved emotional trauma, whether brought into the workplace or experienced there, stops people from living their best lives.
- The Guardian
Children’s and teens roundup – the best new picture books and novels
An ungrammatical egg; a demystifying approach to death; 10 new poets to read aloud; and a stunning gothic mystery
- The Guardian
Sekkoya, Canterbury, Kent: ‘A prime example of why the term “pan-Asian” fills me with foreboding’ – restaurant review
This is the sort of food invented for British people that you’d have got at a Cantonese restaurant back in 1994
- The Guardian
Justice: Hyperdrama review – an uncertain return to the dancefloor
The French producer duo attempt a return to their roots, but the results are a little too polished
- The Guardian
Soldier Sailor by Claire Kilroy audiobook review – a thrillingly blunt take on new motherhood
Narrator Simone Collins leans into the dark humour of life at the domestic coalface, where moments of fierce love jostle with soul-sapping drudgery
- BBC
Co-op Live: Peter Kay says new Manchester arena's fresh delay is 'very disappointing'
The comedian's appearances at Manchester's troubled Co-op Live venue are postponed for a second time.
- Engadget
Engadget Podcast: Why TikTok will never be the same again
Biden passed the TikTok divestment bill -- now what?
- The Telegraph
LIV rebels Jon Rahm and Tyrrell Hatton handed shock lifeline to play in Ryder Cup
Jon Rahm and Tyrrell Hatton have been told they have a pathway to next year’s Ryder Cup and that - contrary to widespread opinion - regulations will not need to be rewritten for the LIV Golf pair to be eligible for Luke Donald’s team.
- Reuters
UPDATE 1-US FDA approves Pfizer's gene therapy for rare bleeding disorder
The U.S. Food and Drug Administration approved Pfizer's gene therapy for hemophilia B on Friday, the second such therapy for the rare bleeding disorder that typically requires regular infusions of a blood-clotting protein. People with hemophilia have a fault in a gene that regulates production of proteins called clotting factors, which can cause spontaneous as well as severe bleeding following injuries or surgery.